These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7003562)

  • 21. Long-term tamoxifen trial halted.
    Marshall E
    Science; 1995 Dec; 270(5242):1562. PubMed ID: 7502061
    [No Abstract]   [Full Text] [Related]  

  • 22. Adaptive trials receive boost.
    Jones D
    Nat Rev Drug Discov; 2010 May; 9(5):345-8. PubMed ID: 20414200
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast Cancer Prevention Trial is a raging success.
    Med Manag Netw; 1998 May; 6(5):5-7. PubMed ID: 10182972
    [No Abstract]   [Full Text] [Related]  

  • 24. Consensus conference. Treatment of early stage breast cancer. National Institutes of Health.
    Conn Med; 1991 Feb; 55(2):101-7. PubMed ID: 2026012
    [No Abstract]   [Full Text] [Related]  

  • 25. The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.
    J Natl Cancer Inst Monogr; 2001; (30):1-152. PubMed ID: 12083020
    [No Abstract]   [Full Text] [Related]  

  • 26. NIH Consensus development conference summary: CEA as a cancer marker.
    J Tenn Med Assoc; 1982 Jan; 75(1):24-5. PubMed ID: 7087455
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials. NCI clinical trials in colon cancer.
    Conley BA; Smiley JK; Cheson BD
    Oncology (Williston Park); 1999 Jun; 13(6):814, 817-8, 820. PubMed ID: 10378219
    [No Abstract]   [Full Text] [Related]  

  • 28. NIH Consensus Development Conference summary. Cervical cancer screening: the Pap smear.
    J Tenn Med Assoc; 1981 May; 74(5):339-42. PubMed ID: 7242079
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6).
    Cheson BD; Carter CL; Sznol M
    Oncology (Williston Park); 1993 Jun; 7(6):43-4. PubMed ID: 8391298
    [No Abstract]   [Full Text] [Related]  

  • 30. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A
    J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract]   [Full Text] [Related]  

  • 31. Breast cancer education: an approach to program planning and evaluation.
    Romano RM; Greenberg R
    Prog Clin Biol Res; 1982; 83():449-56. PubMed ID: 7089005
    [No Abstract]   [Full Text] [Related]  

  • 32. NCI director opts against breast cancer prevention trial in favor of biomarkers.
    Savage L
    J Natl Cancer Inst; 2007 Sep; 99(17):1282-3, 1289. PubMed ID: 17728206
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast Cancer Prevention Trial shows major benefit, some risk.
    Jpn J Clin Oncol; 1998 Jun; 28(6):417-8. PubMed ID: 9730162
    [No Abstract]   [Full Text] [Related]  

  • 34. National Institutes of Health consensus development conference statement CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    J Ark Med Soc; 1981 Jun; 78(1):65-8. PubMed ID: 6454681
    [No Abstract]   [Full Text] [Related]  

  • 35. Steroid receptors in breast cancer. Sponsored by the National Cancer Institute, June 27-29, 1979.
    Natl Inst Health Consens Dev Conf Summ; 1979; 2():33-5. PubMed ID: 398964
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel: current developmental approaches of the National Cancer Institute.
    Arbuck SG
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
    Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
    J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical research. No lifeline for proposed breast cancer prevention trial.
    Kaiser J
    Science; 2007 Jun; 316(5832):1679. PubMed ID: 17588904
    [No Abstract]   [Full Text] [Related]  

  • 40. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit.
    South Med J; 2002 Aug; 95(8):795-7. PubMed ID: 12190211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.